Literature DB >> 15593202

Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.

Sarah J Bingham1, Maya H Buch, Michael A Kerr, Paul Emery, Anabela Tavares Valadäo Barcelos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15593202     DOI： 10.1002/art.20617

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  8 in total

1.  Pharmacotherapy: Is there a place for leflunomide in the treatment of RA?

Authors:  Manathip Osiri
Journal:  Nat Rev Rheumatol       Date:  2010-07       Impact factor: 20.543

Review 2.  Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

Authors:  C Mukhtyar; R Luqmani
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

3.  Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.

Authors:  Renato De Stefano; Elena Frati; Fernando Nargi; Caterina Baldi; Luana Menza; Mohammed Hammoud; Mauro Galeazzi
Journal:  Clin Rheumatol       Date:  2010-01-16       Impact factor: 2.980

Review 4.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Authors:  Moetaza M Soliman; Darren M Ashcroft; Kath D Watson; Mark Lunt; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2011-02-17       Impact factor: 19.103

Review 6.  Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.

Authors:  Peter Bb Jones; Douglas Hn White
Journal:  Open Access Rheumatol       Date:  2010-11-03

7.  Infliximab in the treatment of rheumatoid arthritis.

Authors:  A Perdriger
Journal:  Biologics       Date:  2009-07-13

Review 8.  Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis.

Authors:  Paul Emery; Anthony Sebba; Tom W J Huizinga
Journal:  Ann Rheum Dis       Date:  2013-08-05       Impact factor: 19.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.